• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经皮导线拔除术对心脏器械感染患者生存的早期诊断和治疗效果。

Effect of early diagnosis and treatment with percutaneous lead extraction on survival in patients with cardiac device infections.

机构信息

Cardiac Arrhythmia Center, Washington, District of Columbia, USA.

出版信息

Am J Cardiol. 2012 May 15;109(10):1466-71. doi: 10.1016/j.amjcard.2012.01.360. Epub 2012 Feb 21.

DOI:10.1016/j.amjcard.2012.01.360
PMID:22356796
Abstract

Cardiac device infections (CDIs) represent a serious complication after the implantation of pacemakers and defibrillators. In addition to antimicrobials, complete hardware removal, mostly with percutaneous lead extraction (PLE), is necessary to limit recurrences. However, CDI diagnosis is often difficult and is sometimes delayed, and scarce data exist on how the timing of PLE may affect clinical outcomes. In this study, the in-hospital outcomes of 52 consecutive patients with CDIs who underwent PLE were retrospectively analyze. Co-morbidities such as diabetes mellitus, congestive heart failure, renal insufficiency, and end-stage renal disease were highly prevalent in the study cohort. Patients were divided into group A (bacteremia or device endocarditis) and group B (localized pocket infection). In-hospital mortality was 29% in group A and 5% in group B (p = 0.02) and was due mostly to sepsis. Hospital stays were shorter in group B patients (5.7 vs 21.7 days, p <0.001). Presentation with hypotension was more commonly observed in group A patients and was associated with higher in-hospital mortality, whereas pocket findings correlated with better survival. Postoperative courses after PLE were uneventful in most patients, and no fatal complications were observed. PLE was performed significantly earlier in group B patients (hospitalization day 1.3 vs 7.6, p <0.001). PLE performed within 3 hospitalization days was associated with lower in-hospital mortality (p = 0.01). In conclusion, PLE performed within 3 days from admission is associated with shorter hospitalization and better survival. A timely diagnosis is crucial, particularly in the absence of local findings, because early treatment with PLE is likely to prevent the catastrophic outcomes of unrelenting CDIs.

摘要

心脏器械感染(CDI)是心脏起搏器和除颤器植入后的严重并发症。除了使用抗生素外,还需要完全去除硬件,主要通过经皮导线拔除术(PLE)来限制复发。然而,CDI 的诊断通常较为困难,有时还会出现延迟,并且关于 PLE 时机如何影响临床结果的数据很少。在这项研究中,回顾性分析了 52 例连续接受 PLE 治疗的 CDI 患者的住院期间结局。研究队列中存在多种合并症,如糖尿病、充血性心力衰竭、肾功能不全和终末期肾病。患者被分为 A 组(菌血症或器械心内膜炎)和 B 组(局部囊袋感染)。A 组的住院死亡率为 29%,B 组为 5%(p = 0.02),主要死因是败血症。B 组患者的住院时间更短(5.7 天与 21.7 天,p <0.001)。A 组患者更常出现低血压表现,与较高的住院死亡率相关,而囊袋表现与更好的生存相关。大多数患者在 PLE 后术后过程顺利,未观察到致命并发症。B 组患者的 PLE 明显更早进行(住院第 1.3 天与第 7.6 天,p <0.001)。在入院后 3 天内进行 PLE 与较低的住院死亡率相关(p = 0.01)。总之,入院后 3 天内进行 PLE 与较短的住院时间和更好的生存相关。及时诊断至关重要,特别是在没有局部发现的情况下,因为早期进行 PLE 治疗可能会预防持续 CDI 灾难性结局的发生。

相似文献

1
Effect of early diagnosis and treatment with percutaneous lead extraction on survival in patients with cardiac device infections.经皮导线拔除术对心脏器械感染患者生存的早期诊断和治疗效果。
Am J Cardiol. 2012 May 15;109(10):1466-71. doi: 10.1016/j.amjcard.2012.01.360. Epub 2012 Feb 21.
2
Long-term outcomes following infection of cardiac implantable electronic devices: a prospective matched cohort study.心脏植入式电子设备感染后的长期结局:一项前瞻性匹配队列研究。
Heart. 2012 May;98(9):724-31. doi: 10.1136/heartjnl-2012-301627.
3
Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections.永久性起搏器和植入式心脏复律除颤器感染的管理与预后
J Am Coll Cardiol. 2007 May 8;49(18):1851-9. doi: 10.1016/j.jacc.2007.01.072. Epub 2007 Apr 23.
4
Timing of the most recent device procedure influences the clinical outcome of lead-associated endocarditis results of the MEDIC (Multicenter Electrophysiologic Device Infection Cohort).最近一次器械操作的时间影响了与器械相关的心内膜炎临床结果,这是 MEDIC(多中心电生理装置感染队列)研究的结果。
J Am Coll Cardiol. 2012 Feb 14;59(7):681-7. doi: 10.1016/j.jacc.2011.11.011.
5
[Infectious endocarditis].[感染性心内膜炎]
Dtsch Med Wochenschr. 2010 Apr;135(14):706-11. doi: 10.1055/s-0030-1251919. Epub 2010 Mar 31.
6
Management of cardiac device-related infections: a review of protocol-driven care.心脏器械相关感染的管理:基于方案的治疗综述。
Int J Cardiol. 2013 Jun 5;166(1):55-60. doi: 10.1016/j.ijcard.2011.09.071. Epub 2011 Oct 26.
7
Cardiac device-related endocarditis complicated by spinal abscess.心脏装置相关性心内膜炎并发脊柱脓肿。
Pacing Clin Electrophysiol. 2012 Mar;35(3):269-74. doi: 10.1111/j.1540-8159.2011.03288.x. Epub 2011 Dec 8.
8
Percutaneous pacemaker and implantable cardioverter-defibrillator lead extraction in 100 patients with intracardiac vegetations defined by transesophageal echocardiogram.经食管超声心动图定义的 100 例心内膜赘生物患者的经皮起搏器和植入式心脏复律除颤器导线拔除术。
J Am Coll Cardiol. 2010 Mar 2;55(9):886-94. doi: 10.1016/j.jacc.2009.11.034.
9
[The surgical treatment of electrocardiostimulator implantation septic complications with the system preservation].[保留系统的心脏电刺激器植入术后感染并发症的外科治疗]
Khirurgiia (Mosk). 2012(9):4-8.
10
Outcomes in patients with cardiovascular implantable electronic devices and bacteremia caused by Gram-positive cocci other than Staphylococcus aureus.心血管植入式电子设备患者和革兰阳性球菌(除金黄色葡萄球菌外)引起的菌血症患者的结局。
Circ Arrhythm Electrophysiol. 2010 Dec;3(6):639-45. doi: 10.1161/CIRCEP.110.957514. Epub 2010 Sep 18.

引用本文的文献

1
Long-Term Complications Related to Cardiac Implantable Electronic Devices.与心脏植入式电子设备相关的长期并发症
J Clin Med. 2025 Mar 18;14(6):2058. doi: 10.3390/jcm14062058.
2
Retrospective Review Identifying Patients With Bacteremia and Intracardiac Devices With an Electronic Health Record Advisory.通过电子健康记录咨询进行回顾性审查以识别患有菌血症和心内装置的患者。
Cureus. 2024 Nov 19;16(11):e74012. doi: 10.7759/cureus.74012. eCollection 2024 Nov.
3
EANM/SNMMI guideline/procedure standard for [F]FDG hybrid PET use in infection and inflammation in adults v2.0.
欧洲核医学协会/美国核医学与分子影像学会关于成人感染与炎症中[F]FDG 混合正电子发射断层显像应用的指南/程序标准 v2.0
Eur J Nucl Med Mol Imaging. 2025 Jan;52(2):510-538. doi: 10.1007/s00259-024-06915-3. Epub 2024 Oct 10.
4
Utility of an Externalized Temporary Transvenous Implantable Cardioverter-defibrillator System in the Setting of Ventricular Tachycardia Storm and Concurrent Device Infection Requiring Extraction.外置临时经静脉植入式心脏复律除颤器系统在室性心动过速风暴及并发需要拔除装置的器械感染情况下的应用
J Innov Card Rhythm Manag. 2024 Jul 15;15(7):5930-5934. doi: 10.19102/icrm.2024.15071. eCollection 2024 Jul.
5
Prevention and Risk Assessment of Cardiac Device Infections in Clinical Practice.临床实践中心脏设备感染的预防与风险评估
J Clin Med. 2024 May 4;13(9):2707. doi: 10.3390/jcm13092707.
6
Infection remediation after septic device extractions: analysis of three treatment strategies including a 1-year follow-up.感染性装置拔除后的感染修复:三种治疗策略分析及一年随访
Front Cardiovasc Med. 2024 Jan 11;10:1342886. doi: 10.3389/fcvm.2023.1342886. eCollection 2023.
7
[Lead extraction in cardiac implantable electronic devices].[心脏植入式电子设备中的导线拔除]
Herzschrittmacherther Elektrophysiol. 2023 Dec;34(4):339-350. doi: 10.1007/s00399-023-00963-2. Epub 2023 Nov 2.
8
Contemporary Features and Management of Endocarditis.感染性心内膜炎的当代特征与管理
Diagnostics (Basel). 2023 Sep 28;13(19):3086. doi: 10.3390/diagnostics13193086.
9
Cardiac implantable electronic device implantation and device-related infection.心脏植入式电子设备植入与设备相关感染。
Europace. 2023 Aug 2;25(9). doi: 10.1093/europace/euad208.
10
Advances in Molecular Imaging in Infective Endocarditis.感染性心内膜炎分子成像的进展
Vaccines (Basel). 2023 Feb 12;11(2):420. doi: 10.3390/vaccines11020420.